Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB)

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

April 1, 2023

Study Completion Date

April 1, 2023

Conditions
Urinary Tract InfectionsBladder CancerUrologic Surgical Procedures
Interventions
DRUG

Fosfomycin Tromethamine 3G Sachet

Is the prophylactic drug which will be used in the intervention group.

DRUG

Amikacin

Is the prophylactic drug which will be used in the control group.

Trial Locations (1)

14080

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City

All Listed Sponsors
collaborator

Laboratorios Senosiain, S.A. de C.V.

INDUSTRY

lead

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

OTHER

NCT04209192 - Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB) | Biotech Hunter | Biotech Hunter